Cetera Investment Advisers Ishares Tr Genomics Immunology Transaction History
Cetera Investment Advisers
- $49.2 Billion
- Q1 2025
A detailed history of Cetera Investment Advisers transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Cetera Investment Advisers holds 10,861 shares of IDNA stock, worth $219,718. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,861
Previous 11,361
4.4%
Holding current value
$219,718
Previous $257,000
13.62%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IDNA
# of Institutions
57Shares Held
2.19MCall Options Held
0Put Options Held
0-
Ubs Group Ag504KShares$10.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY336KShares$6.8 Million0.0% of portfolio
-
Wharton Business Group, LLC Malvern, PA285KShares$5.78 Million0.26% of portfolio
-
Bank Of America Corp Charlotte, NC275KShares$5.56 Million0.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL125KShares$2.53 Million0.0% of portfolio